Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • DonDolowy
    Member
    • Oct 2012
    • 56

    #1

    Taqman and RNA-seq do not correlate

    Dear all,

    some time ago we did Taqman for a couple of candidate genes on some human samples, that showed downregulation of these genes. We therefore decided to go for a low-depth RNA-seq on these 38 samples, but it turns out that the results are no near what we see with Taqman where we used verified probes from Life Technologies.

    We are a bit lost now and dont know what to trust. I would appreciate any input! Thanks a lot.

    Info about sequencing process:
    19-plexing 2x50bp strand-specific on a HiSeq2500.

    FastQC files showed great quality but a bit of contamination of index sequences, so I trimmed the reads with TrimGalore. Ran FastQC again and everything was great. I mapped to hg19 (UCSC from iGenome) using the Tophat 2.0.8. I get around 7-10 million mapped reads.
    I then continued with Cufflinks, Cuffquant and Cuffnorm (without de novo discovery). I also tried using DESeq 2. Get about the same results (also independent on whether I use classic.fpkm, quartile og geometric normalization).

    Thanks a lot - appreciate your input!
  • mbblack
    Senior Member
    • Aug 2009
    • 245

    #2
    When you did the qPCR, just how down-regulated were these genes? Where the differences in expression large or small?

    RNA-seq is very problematic when looking at/for low level expression changes. The problem being that these will be low count genes in your mapped read set, and they will have very large variance (across your biological replicates). Those low count & high variance genes often will not pass typical thresholds (FDR or Fold Change cutoffs) for detection of differential expression.

    In fact, in my own experience, conventional microarrays were much better at characterizing low level of expression change, while RNA-seq did perform better as expression levels increased (i.e. as feature count increased).
    Michael Black, Ph.D.
    ScitoVation LLC. RTP, N.C.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...